abstract |
The present invention discloses a process for purification of prostaglandins of formula (1) into enantiomerically pure isomer of formula (2) by reverse phase preparative HPLC, and converting said isomer into prostaglandin derivative of formula (3). The prostaglandin derivative in this invention relates to PGF 2α analogues |